Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH 4 loading test and PAH analysis

Molecular Genetics and Metabolism

Volumn 106, Issue 3, 2012, Pages 264-268

  Zimmermann, M ^a   Jacobs, P ^a,b   Fingerhut, R ^a   Torresani, T ^a   Thony B ^a   Blau, N ^a,c   Baumgartner, M R ^a   Rohrbach, M ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b BERN UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

PKU; Simplified diet versus classical diet

Indexed keywords

PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TETRAHYDROBIOPTERIN;

ADOLESCENT; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; DIET THERAPY; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; FRUIT; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERPHENYLALANINEMIA; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; PHENOTYPIC VARIATION; PHENYLKETONURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIMPLIFIED PHENYLALANINE RESTRICTED DIET; TREATMENT DURATION; VEGETABLE; WORLD HEALTH ORGANIZATION;

BIOPTERIN; COHORT STUDIES; DIET; DIET THERAPY; FEMALE; GENETIC VARIATION; HUMANS; INFANT, NEWBORN; MALE; PHENOTYPE; PHENYLALANINE; PHENYLALANINE HYDROXYLASE; PHENYLKETONURIAS; POLYCYCLIC HYDROCARBONS, AROMATIC;

EID: 84862587034     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.04.016     Document Type: Article

References (30)

1. Scriver C.R., Kaufman S. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. The Metabolic and Molecular Bases of Inherited Disease 2001, 1667-1724. McGraw-Hill, New York. 8th edn. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs, B. Vogelstein (Eds.).
2. Blau Sapropterin dihydrochloride for phenylketonuria and tetrahydrobiopterin deficiency. Expert. Rev. Endocrinol. Metab. 2010, 5:483-494.
3. Surtees R., Blau N. The neurochemistry of phenylketonuria. Eur. J. Pediatr. 2000, 159(Suppl. 2):S109-S113.
4. Treacy E, Childs B, Scriver CR. Response to treatment in hereditary metabolic disease: 1993 survey and 10-year comparison. In. 1995/02/01 ed; 1995:359-367.
5. Scriver C.R., Treacy E.P. Is there treatment for "genetic" disease?. Mol. Genet. Metab. 1999, 68(2):93-102.
6. Walter J.H., White F.J., Hall S.K., MacDonald A., Rylance G., Boneh A., Francis D.E., Shortland G.J., Schmidt M., Vail A. How practical are recommendations for dietary control in phenylketonuria?. Lancet 2002, 360:55-57.
7. Sarkissian C.N., Gamez A., Scriver C.R. What we know that could influence future treatment of phenylketonuria. J. Inherit. Metab. Dis. 2009, 32:3-9.
8. MacDonald A., Rylance G., Hall S.K., Asplin D., Booth I.W. Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet. Arch. Dis. Child. 1996, 74:412-417.
9. MacDonald A., Rylance G., Davies P., Asplin D., Hall S.K., Booth I.W. Free use of fruits and vegetables in phenylketonuria. J. Inherit. Metab. Dis. 2003, 26:327-338.
10. Levy H.L., Milanowski A., Chakrapani A., Cleary M., Lee P., Trefz F.K., Whitley C.B., Feillet F., Feigenbaum A.S., Bebchuk J.D., Christ-Schmidt H., Dorenbaum A. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J. Pediatr. 1999, 135:375-378.
11. Levy H.L., Milanowski A., Chakrapani A., et al. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet 2007, 370:504-510.
12. Muntau A.C., Roschinger W., Habich M., Demmelmair H., Hoffmann B., Sommerhoff C.P., Roscher A.A. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N. Engl. J. Med. 2002, 347:2122-2132.
13. Fiege B., Blau N. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria. J. Pediatr. 2007, 150:627-630.
14. Zurfluh M.R., Zschocke J., Lindner M., Feillet F., Chery C., Burlina A., Stevens R.C., Thony B., Blau N. Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Hum. Mutat. 2008, 29:167-175.
15. Kayaalp E., Treacy E., Waters P.J., Byck S., Nowacki P., Scriver C.R. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations. Am. J. Hum. Genet. 1997, 61:1309-1317.
16. Gennaccaro M., Waisbren S.E., Marsden D. The knowledge gap in expanded newborn screening: survey results from paediatricians in Massachusetts. J. Inherit. Metab. Dis. 2005, 28:819-824.
17. Marsden D., Levy H. Advances in Phenylketonuria and Tetrahydropterin 2006, 92-103. SPS Verlagsgesellschaft GmbH, Heilbronn.
18. Lindner M. Treatment of phenylketonuria variants: European recommendation. PKU and BH4: Advances in Pehynlketonuria and Tertahydropterin 2006, 180-187. SPS verlagsgesellschaft GmbH, Heilbronn. N. Blau (Ed.).
19. Blau N., van Spronsen F.J., Levy H.L. Phenylketonuria. Lancet 2010, 376:1417-1427.
20. Fiege B., Bonafe L., Ballhausen D., Baumgartner M., Thony B., Meili D., Fiori L., Giovannini M., Blau N. Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study. Mol. Genet. Metab. 2005, 86(Suppl. 1):S91-S95.
21. Bernegger C., Blau N. High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002. Molecular genetics and metabolism 2002, 304-313.
22. Levy H., Burton B., Cederbaum S., Scriver C. Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment. Mol Genet Metab 2007, 92:287-291.
23. Blau N., Belanger-Quintana A., Demirkol M., Feillet F., Giovannini M., MacDonald A., Trefz F.K., van Spronsen F. Management of phenylketonuria in Europe: survey results from 19 countries. Mol. Genet. Metab. 2009, 99:109-115.
24. Pterins and Related Enzymes in Laboratory Guide to the Methods in Biochemical Genetics 2008, Springer. N. Blau, B. Thöny (Eds.).
25. Opladen T., Abu Seda B., Rassi A., Thony B., Hoffmann G.F., Blau N. Diagnosis of tetrahydrobiopterin deficiency using filter paper blood spots: further development of the method and 5years experience. J. Inherit. Metab. Dis. 2011, 34:819-826.
26. Kostandyan N., Britschgi C., Matevosyan A., Oganezova A., Davtyan A., Blau N., Steinmann B., Thöny B. The spectrum of phenylketonuria genotypes in the Armenian population: identification of three novel mutant PAH alleles. Mol. Genet. Metab. 2011, 104:S93-S96.
27. WHO Joint FAO/WHO Workshop on Fruit and Vegetables for Health: Report of a Joint FAO/WHO Workshop 2004, 21.
28. Camenzind-Frey E., Zybach U., Eichholzer M., Matzke A., Amadò R., Ballmer P.E., Beer M., Darioli R., Hasler K., Lüthy J., Moser U., Sieber R., Trabichet C. Fifth Swiss Report of Nutrition, Programs and Actions to Improve the Eating Habits Swiss Federal Office of Public Health 2005, 897-904.
29. Feillet F., Agostoni C. Nutritional issues in treating phenylketonuria. J. Inherit. Metab. Dis. 2010, 33:659-664.
30. MacDonald A., Gokmen-Ozel H., van Rijn M., Burgard P. The reality of dietary compliance in the management of phenylketonuria. J. Inherit. Metab. Dis. 2010, 33:665-670.